New hope for thalassemia: drug trial targets anemia without transfusions

NCT ID NCT07579949

Not yet recruiting Disease control Sponsor: ScinnoHub Pharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called SNH-119014 in 30 adults with a type of thalassemia that does not require regular blood transfusions. The goal is to see if the drug is safe and helps improve anemia. Participants will be monitored for side effects and how their body responds to the treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-TRANSFUSION DEPENDENT THALASSEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

beta-thalassemia intermedia thalassemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

THALASSEMIA

Contacts and locations

Locations

923rd Hospital of the Joint Logistics Support Force of the People's Liberation Army of China

Nanning, Guangxi, China
Foshan First People's Hospital

Foshan, Guangdong, China
Liuzhou People's Hospital

Liuzhou, Guangxi, China
Maoming People's Hospital

Maoming, Guangdong, China
Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, China
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

Chengdu, Sichuan, China
The First Affiliated Hospital of Guangxi Medical University

Nanning, Guangxi, China
The First Affiliated Hospital of Hainan Medical University

Haikou, Hunan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.